Twist Bioscience Corporation (TWST)
NASDAQ: TWST · IEX Real-Time Price · USD
53.90
+0.34 (0.63%)
Jul 19, 2024, 4:00 PM EDT - Market closed

Twist Bioscience Revenue

Twist Bioscience had revenue of $277.49M in the twelve months ending March 31, 2024, with 21.79% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $75.30M with 25.13% year-over-year growth. In the fiscal year ending September 30, 2023, Twist Bioscience had annual revenue of $245.11M with 20.41% growth.

Revenue (ttm)
$277.49M
Revenue Growth
+21.79%
P/S Ratio
11.31
Revenue / Employee
$301,943
Employees
919
Market Cap
3.14B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 2023245.11M41.54M20.41%
Sep 30, 2022203.57M71.23M53.83%
Sep 30, 2021132.33M42.23M46.87%
Sep 30, 202090.10M35.72M65.67%
Sep 30, 201954.39M28.96M113.89%
Sep 30, 201825.43M14.66M136.16%
Sep 30, 201710.77M8.50M374.53%
Sep 30, 20162.27M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Oscar Health 6.54B
Amedisys 2.25B
GoodRx Holdings 764.16M
Inari Medical 520.66M
iRhythm Technologies 513.17M
Amicus Therapeutics 423.49M
Denali Therapeutics 295.39M
ADMA Biologics 283.18M
Revenue Rankings